A personal care composition
A personal care composition combining carboxymethyl cysteine and C6-C12-dicarboxylic acid amide synergistically upregulates ATG5 gene expression, addressing skin aging issues by improving elasticity and reducing wrinkles and sagging.
WO2026027147A1 Publication Date: 2026-02-05UNILEVER IP HLDG BV +2
0 Cites 0 Cited by
Patent Information
- Application Number
- PCT/EP2025/068444
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-23
- Filing Date
- 2025-06-30
- Publication Date
- 2026-02-05
AI Technical Summary
Technical Problem
Existing personal care compositions fail to effectively upregulate the expression of ATG5 gene, which is crucial for controlling skin aging through autophagy, leading to issues like dryness, wrinkles, and loss of elasticity.
Method used
A personal care composition comprising carboxymethyl cysteine compound and C6-C12-dicarboxylic acid amide or its salt, synergistically upregulates the expression of ATG5 gene, enhancing skin benefits such as elasticity, reducing wrinkles, and reducing sagging.
Benefits of technology
The composition significantly enhances skin elasticity, reduces wrinkles, and minimizes sagging by upregulating ATG5 gene expression, demonstrating a synergistic effect when both components are combined.
✦ Generated by Eureka AI based on patent content.
Abstract
Disclosed is a personal care composition comprising: (a) carboxymethyl cysteine compound and (b) C6-C12-dicarboxylic acid amide and / or salt thereof.
Need to check novelty before this filing date? Find Prior Art